Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Antonio, Texas 78229


Purpose:

This study is intended to assess safety and tolerability of ASP1941 compared to placebo in adult subjects with type 2 diabetes mellitus


Study summary:

Trial includes a two week washout period before entering the treatment period for subjects on oral anti-diabetic medication.


Criteria:

Inclusion Criteria: - Established diagnosis of type 2 diabetes mellitus - HbA1c value between 7.0 and 10.0% - Body mass index between 20 and 45 kg/m2 Exclusion Criteria: - Established diagnosis of type 1 diabetes mellitus - Serum creatinine > upper limit of normal range - Proteinuria (microalbumin/creatinine ratio > 300 mg/g) - Urinary tract infection - Severe uncontrolled Hypertension - Significant renal, hepatic or cardiovascular disease - HIV Positive - History of drug or alcohol abuse/dependency


NCT ID:

NCT00790660


Primary Contact:

Study Director
use Central Contact
Astellas Pharma Global Development


Backup Contact:

N/A


Location Contact:

San Antonio, Texas 78229
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.